Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

计划入组 315 人 · 首次发布于 2024 年 12 月 17 日

Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura

计划入组 163 人 · 首次发布于 2024 年 12 月 6 日

A Phase 3, multi-center, prospective, randomized, double-blind, placebo- controlled study to evaluate the effectiveness and safety of ZP5-9676 for the treatment of Hookworm (Ancylostoma duodenale and Necator americanus), Ascaris lumbricoides, and Trichuris trichiura in pediatric and adult Participants

计划入组 300 人

ascaris polypeptide antigens

Oxantel

C₁₃H₁₆N₂O · Rx

NNRTI (AiCuris)

Ascyrus Medical LLC

United States

ACLARIS THERAPEUTICS INC

India

AiCuris GmbH & Co. KG

Germany

EMA Safety Committee Initiates Review of Levamisole Following Fatal Leukoencephalopathy Case

EMA Recommends Withdrawal of Levamisole Medicines from EU Market Due to Serious Brain Side Effects

Aclaris Therapeutics Initiates Phase IIa Trial of ATI-2138 for Atopic Dermatitis